{"references": ["Abd El-Ghany W.A., Madian K. Control of experimental colisepticaemia in broiler chickens using sarafloxacin. Life Sci. J. 2011. V. 8. N 3. P.318-328.", "Achan J., Talisuna A.O., Erhart A., Yeka A., Tibenderana J.K., Baliraine F.N., Rosenthal P.J., D'Alessandro U. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malaria J. 2011. V. 10. N 144, P.12.", "Adjei M.D., Heinze T.M., Deck J., Freeman J.P., Williams A.J., Sutherland J.B. Transformation of the antibacterial agent norfloxacin by environmental mycobacteria. Appl. Environ. Microbiol. 2006. V. 72. N 9. P.5790-5793.", "Adjei M.D., Heinze T.M., Deck J., Freeman J.P., Williams. A.J., Sutherland J.B. Acetylation and nitrosation of ciprofloxacin by environmental strains of mycobacteria. Can. J. Microbiol. 2007. V. 53. P.144-147.", "Agarwal A., Srivastava K., Puri S.K., Chauhan P.M.S. Synthesis of substituted indole derivatives as a new class of antimalarial agents. Bioorg. Med. Chem. Lett. 2005. V. 15. P. 3133\u20133136.", "Ahmad S., Henderson K., Dunsday G., Zachariou M. Microbial biotransformations: stereoselective synthesis of pharmaceutical drug precursors. Australas Biotechnol. 2001. N 11. P.26\u201328.", "Ahn K.H., Shin Y-S. Synthesis of 1,4-dideoxy-1,4-imino-D-arabinitol (D-AB-1) through a divergent approach. Bull. Korean Chem. Soc. 1997. V. 18. N 11. P.1192-1195.", "Aislabie J., Bej A.K., Hurst H., Rothenburger S., Atlas R.M. Microbial degradation of quinoline and methylquinolines. Appl. Environ. Microbiol. 1990. N 56. P.345\u2013351.", "Aislabie J., Rothenburger S., Atlas R.M. Isolation of microorganisms capable of degrading isoquinoline under aerobic conditions. Appl. Environ. Microbiol. 1989. V. 55. P.3247\u20133249.", "Amjad H., Iqbal J., Naeem M. Estimation of selected residual antibiotics in muscle, kidney, liver and egg of layer chicken. Proc. Pakistan Acad. Sci. 2006. V. 43. N 1. P.29-37.", "Andersson M.I., MacGowan A.P. Development of the quinolones. J. Antimicrob. Chemother. 2003. V. 51. Suppl. S1. P.1-11", "Andries K., Verhasselt P., Guillemont J., G\u00f6hlmann H.W.H, Neefs J-M., Winkler H., Van Gestel J., Timmerman P., Zhu M., Lee E., Williams P., de Chaffoy D., Huitric E., Hoffner S., Cambau E., Truffot-Pernot C., Lounis N., Jarlier V. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science. 2005. V. 307. P.223\u2013227.", "Andriole V.T. The quinolones: prospects. In: The Quinolones. - 3rd ed. (Andriole V.T., ed.) San Diego: Academic Press, 2000. C.477\u201395.", "Appelbaum PC, Hunter PA. The fluoroquinolone antibacterials: past, present and future perspectives. Int. J. Antimicrob. Agents. 2000. V. 16. P.5-15.", "Arantes V., Jellison J, Goodell G. Peculiarities of brown-rot fungi and biochemical Fenton reaction with regard to their potential as a model for bioprocessing biomass. Appl. Microbiol. Biotechnol. 2012. 94: 323-338.", "Ara\u00fajo N.C.P., Barton V., Jones M., Stocks P.A., Ward S.A., Davies J., Bray P.G., Shone A.E., Cristiano M.L.S., O'Neill P.M. Semi-synthetic and synthetic 1,2,4-trioxaquines and 1,2,4-trioxolaquines: synthesis, preliminary SAR and comparison with acridine endoperoxide conjugates. Bioorg Med Chem Lett, 2009. 19:2038\u20132043", "Archelas A., Furneron I.D., Furstoss R. Microbial transformations 11. Regioselective hydroxylation of \u03b2-lactams by the fungus Beauveria sulfurescens. Tetrahedron Lett. 1988. 29(50):6611-6613. doi: 10.1016/S0040-4039(00)82410-7", "Archelas A., Furstoss R., Srairi D., Maurey G. Transformations microbiologiques, 5. Hydroxylation microbiologique de lactames, d'amides et d'imides monocycliques par le champignon Beauveria sulfurescens. Bull Soc Chim Fr. 1986. 2:234-238.", "Auparakkitanon S, Noonpakdee W, Ralph RK, Denny WA, Wilairat P Antimalarial 9-anilinoacridine compounds directed at hematin. Antimicrob Agents Chemother. 2003. 47:3708\u20133712.", "Aurrecoechea JM, Bustos F, L\u00f3pez B, Saornil C, Suero R. A new entry into 3-hydroxypyrrolidine derivatives from protected \u03b1- or \u03b2-amino esters. Arkivoc. 2009. 11:94-104.", "Baird J.K. Resistance to chloroquine unhinges vivax malaria therapeutics. Antimicrob. Agents. Chemother. 2011. 55:1827\u20131830.", "Baker P. Biotransformations. Lab Pract. 1987. 36(7):46-47.", "Ball P. Quinolone generations: natural history or natural selection? J. Antimicrob. Chemother. 2000a. V. 46 Suppl. T1. P.17-24.", "Ball P. The quinolones: history and overview. In: The Quinolones, 3rd ed. (Andriole V.T., ed.) San Diego: Academic Press, 2000. p. 1-31.", "Banasik M, Komura H, Shimoyama M, Ueda K. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase. J Biol Chem. 1992. 267:1569\u20131575.", "Barreiros L, Fernandes A, Ferreira ACS, Pereira H, Bastos MMSM, Manaia CM, Nunes OC. New insights into a bacterial metabolic and detoxifying association responsible for the mineralization of the thiocarbamate herbicide molinate. Microbiology. 2008. 154:1038-1046. doi: 10.1099/mic.0.2007/015297-0", "Basco L.K., Mitaku S., Skaltsounis A.-L., Ravelomanantosoa N., Tillequin F., Koch M., LeBras J. In vitro activities of furoquinoline and acridone alkaloids against Plasmodium falciparum. Antimicrob. Agents Chemother. 1994. V. 38. N 5. P.1169-1171.", "Bertrand L, Kremsner PG Clindamycin as an antimalarial drug: review of clinical trials. Antimicrob Agents Chemother. 2002. 46(8):2315-2320. doi: 10.1128/AAC.46.8.2315-2320.2002", "Betts R.E., Walters D.E., Rosazza J. Microbial transformations of antitumor compounds. 1. Conversion of acronycine to 9-hydroxyacronycine by Cunninghamella echinulata. J. Med. Chem. 1974. V. 17. N 6. P.599-602.", "Bianchi D, Bosetti A, Cidaria D, Bernardi A, Gagliardi I, D'Amico P (1997) Oxidation of polycyclic aromatic heterocycles by Pseudomonas fluorescens TTC1. Appl Microbiol Biotechnol 47:596\u2013599", "Boaventura MAD, Lopes RFAP, Takahashi JA (2004) Microorganisms as tools in modern chemistry: the biotransformation of 3-indolylacetonitrile and tryptamine by fungi. Braz J Microbiol 35:345\u2013347", "Boibessot I, Turner CMR, Watson DG, Goldie E, Connel G, McIntosh A, Grant MH, Skellern GG (2002) Metabolism and distribution of phenanthridine trypanocides in Trypanosoma brucei. Acta Tropica 84:219\u2013228", "Bot C, Hall BS, Bashir N, Taylor MC, Helsby NA, Wilkinson SR (2010) Trypanocidal activity of aziridinyl nitrobenzamide prodrugs. Antimicrob. Agents Chemother. 54(10):4246-4252. doi: 10.1128/AAC.00800-10", "Boteva A. A., Krasnykh O. P. The methods of synthesis, modification, and biological activity of 4-quinolones (review). Chem. Heterocycl. Compds. 2009. V. 45. N 7. P.757-785.", "Bott G, Lingens F (1991) Microbial metabolism of quinoline and related compounds. IX. Degradation of 6-hydroxyquinoline and quinoline by Pseudomonas diminuta 31/1 Fa1 and Bacillus circulans 31/2 A1. Biol Chem Hoppe-Seyler 372:381\u2013383", "Boyd DR, McMordie RAS, Porter HP, Dalton H, Jenkins RO, Howarth OW (1987) Metabolism of bicyclic aza-arenes by Pseudomonas putida to yield vicinal cis-dihydrodiols and phenols. J Chem Soc Chem Commun 1987:1722\u20131724", "Boyd DR, Sharma ND, Dorrity MRJ, Hand MV, McMordie RAS, Malone JF, Porter HP, Dalton H, Chima J, Sheldrake GN (1993) Structure and stereochemistry of cis-dihydro diol and phenol metabolites of bicyclic azaarenes from Pseudomonas putida UV4. J Chem Soc Perkin Trans 1 1993:1065\u20131071", "Boyd DR, Sharma ND, Modyanova LV, Carroll JG, Malone JF, Allen CCR, Hamilton JTG, Gibson DT, Parales RE, Dalton H (2002) Dioxygenase-catalyzed cis-dihydroxylation of pyridine-ring systems. Can J Chem 80:589\u2013600", "Bressler DC, Fedorak PM (2000) Bacterial metabolism of fluorene, dibenzofuran, dibenzothiophene, and carbazole. Can J Microbiol 46:397\u2013409", "Brighty K.E., Gootz T.D. Chemistry and mechanism of action of the quinolone antibacterials. In: The Quinolones. 3rd ed. (Andriole V.T., ed.) San Diego: Academic Press, 2000. P.33\u201397.", "Brocks DR, Mehvar R (2003) Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs. Clin Pharmacokinet 42:1359\u20131382", "Cattoir V, Nordmann P. Plasmid-mediated quinolone resistance in Gram-negative bacterial species: an update. Curr. Med. Chem. 2009. 16: 1028-1046.", "Chang D, Feiten H-J, Engesser KH, Van Beilen JB, Witholt B, Li Z (2002) Practical syntheses of N-substituted 3-hydroxyazetidines and 4-hydroxypiperidines by hydroxylation with Sphingomonas sp. HXN-200. Org Lett. 4(11):1859-1862. doi: 10.1021/ol025829s", "Chauhan SS, Sharma M, Chauhan PMS (2010) Trioxaquines: hybrid molecules for the treatment of malaria. Drug News Perspect 23:632\u2013646", "Chawla R, Singh AK, Yadav LDS (2013) Organocatalysis in synthesis and reactions of epoxides and aziridines. RSC Advances. 3(29):11385-11403. doi: 10.1039/C3RA00175J", "Chen P, Gao M, Wang DX, Zhao L, Wang MX (2012) Enantioselective biotransformations of racemic and meso pyrrolidine-2,5-dicarboxamides and their application in organic synthesis. J Org Chem. 77:4063-4072. doi: 10.1021/jo300412j", "Chen Y., Rosazza J.P.N., Reese C.P., Chang H.-Y., Nowakowski M.A., Kiplinger J.P. Microbial models of soil metabolism: biotransformations of danofloxacin. J. Ind. Microbiol. Biotechnol. 1997. V. 19. P.378\u2013384.", "Clark AM, Hufford CD, Gupta RC, Puri RK, McChesney JD (1984a) Microbial transformation of primaquine by Candida tropicalis. Appl Environ Microbiol 47:537\u2013539.", "Clark AM, Hufford CD, Puri RK, McChesney JD (1984b) Production of a novel dimeric metabolite of primaquine by Streptomyces rimosus. Appl Environ Microbiol 47:540\u2013543.", "Cosl\u00e9dan F, Fraisse L, Pellet A, Guillou F, Mordm\u00fcller B, Kremsner PG, Moreno A, Mazier D, Maffrand J-P, Meunier B (2008) Selection of a trioxaquine as an antimalarial drug candidate. Proc Nat Acad Sci USA 105:17579\u201317584.", "Cui M, Chen F, Fu J, Sheng G, Sun G (2004) Microbial metabolism of quinoline by Comamonas sp. World J Microbiol Biotechnol 20:539\u2013543.", "Dalhoff A, Schmitz F-J. In vitro antibacterial activity and pharmacodynamics of new quinolones. Eur. J. Clin. Microbiol. Infect. Dis. 2003. 22: 203-221.", "Deretic V, Pag\u00e1n-Ramos E, Zhang Y, Dhandayuthapani S, Via LE (1996) The extreme sensitivity of Mycobacterium tuberculosis to the front-line antituberculosis drug isoniazid. Nature Biotechnol 14:1557\u20131561.", "Dexian W, Meixiang W (2010) Biotransformations of three-membered (hetero) cyclic nitriles and their applications in organic synthesis. Progress in Chemistry. 22(7):1397-1402.", "D'hooghe M, Kenis S, Vervisch K, Lategan C, Smith PJ, Chibale K, De Kimpe N (2011) Synthesis of 2-(aminomethyl)aziridines and their microwave-assisted ring opening to 1,2,3-triaminopropanes as novel antimalarial pharmacophores. Eur J Med Chem. 46(2):579\u2013587. doi: 10.1016/j.ejmech.2010.11.037", "Diethelm S, Carreira EM (2013) Total Synthesis of (\u00b1)-Gelsemoxonine. J Am Chem Soc. 135(23):8500-8503. doi: 10.1021/ja208617c", "Divo A.A., Sartorelli A.C., Patton C.L., Bia F.J. Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 1988. V. 32. N 8. P.1182-1186.", "Dovgilevich E.V., Parshikov I.A., Modyanova L.V., Terent'ev P.B., Bulakhov G.A. A novel microbial transformation of \u03b3-carboline derivative 3,6-dimethyl-9-[2-(2-methylpyrid-5-yl)ethyl]-1,2,3,4-tetrahydro-\u03b3-carboline. Mendeleev Communications. 1991. 1:42\u201343", "Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 1997. 61: 377-392.", "Duran N, De Conti R, Rodrigues JAR (2000) Biotransformations by microorganisms, organisms and enzymes: state of art. Bol Soc Chil Quim. 45(1):109-121", "Duran N, De Conti R, Rodrigues JAR (2000) Biotransformations by microorganisms, organisms and enzymes: state of art. Bol Soc Chil Qu\u00edm 45:109\u2013121.", "Edens F. W., Qureshi R. A., Parkhurst C. R., Qureshi M. A., Havenstein G. B., Casas I. A. Characterization of two Escherichia coli isolates associated with poult enteritis and mortality syndrome. Poult. Sci. 1997. V. 76. P.1665\u20131673.", "Ensley BD, Ratzkin BJ, Osslund TD, Simon MJ, Wackett LP, Gibson DT (1983) Expression of naphthalene oxidation genes in Escherichia coli results in the biosynthesis of indigo. Science 222:167\u2013169.", "Faber K (2004) Biotransformations in Organic Chemistry. Springer, Heidelberg. 321P.", "Faber K (2011) Biotransformations in Organic Chemistry: A Textbook, 6th ed. Springer, Berlin. 434 p.", "Fattorusso E, Taglialatela-Scafati O (2009) Marine Antimalarials. Mar Drugs. 7:130-152. doi: 10.3390/md7020130", "Fetzner S (1998) Bacterial degradation of pyridine, indole, quinoline, and their derivatives under different redox conditions. Appl Microbiol Biotechnol 49:237\u2013250.", "Fetzner S, Tshisuaka B, Lingens F, Kappl R, H\u00fcttermann J (1998) Bacterial degradation of quinoline and derivatives\u2013pathways and their biocatalysts. Angew Chem Int Ed 37:576\u2013597.", "Feula A, Male L, Fossey JS (2010) Diastereoselective preparation of azetidines and pyrrolidines. Org Lett. 12(21):5044\u20135047. doi: 10.1021/ol102215e", "Fujioka H., Nishiyama Y., Furukawa H., Kumada N. In vitro and in vivo activities of atalaphillinine and related acridone alkaloids against rodent malaria. // Antimicrob. Agents Chemother. 1989. V. 33. P.6-9.", "Fujioka, H., Kato N., Fujita M., Fujimura K., Nishiyama Y. Activities of new acridone alkaloid derivatives against Plasmodium yoelii in vitro. Arzneim.-Forsch./Drug Res. 1990. V. 40. P.1026-1029.", "F\u00fcrmeier S, Metzger JO (2003) Fat-Derived aziridines and their N-substituted derivatives: biologically active compounds based on renewable raw materials. Eur J Org Chem. 4:649-659. doi: 10.1002/ejoc.200390105", "Gatti D., Adami S. New bisphosphonates in the treatment of bone diseases. Drugs Aging. 1999. 15:285\u2013296.", "Ge J-F, Arai C, Yang M, Md AB, Lu J, Ismail NSM, Wittlin S, Kaiser M, Brun R, Charman SA, Nguyen T, Morizzi J, Itoh I, Ihara M (2010) Discovery of novel benzo[a]phenoxazine SSJ-183 as a drug candidate for malaria. ACS Med Chem Lett 1:360\u2013364.", "Georg GI, Guan X (1992) Asymmetric synthesis of \u03b1-alkylated \u03b1-amino acids: azocane-2-carboxylic acids. Tetrahedron Lett. 33:17-20. doi: 10.1016/S0040-4039(00)77662-3", "Ghorai MK, Das K, Kumar A (2007) A convenient synthetic route to enantiopure N-tosylazetidines from \u03b1-amino acids. Tetrahedron Lett. 48:2471\u20132475. doi: 10.1016/j.tetlet.2007.02.033", "Gieg LM, Otter A, Fedorak PM (1996) Carbazole degradation by Pseudomonas sp. LD2: metabolic characteristics and the identification of some metabolites. Environ Sci Technol 30:575\u2013585", "Gomtsyan A, Bayburt EK, Schmidt RG, Zheng GZ, Perner RJ, Didomenico S, Koenig JR, Turner S, Jinkerson T, Drizin I, Hannick SM, Macri BS, McDonald HA, Honore P, Wismer CT, Marsh KC, Wetter J, Stewart KD, Oie T, Jarvis MF, Surowy CS, Faltynek CR, Lee C-H (2005) Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties. J Med Chem 48:744\u2013752", "Grant DJW, Al-Najjar TR (1976) Degradation of quinoline by a soil bacterium. Microbios 15:177\u2013189.", "Grishina GV, Veselov IS, Nelyubina YV, Surovaya AN, Zefirov NS (2011) Optically pure trans-1-benzyl-4-aminopiperidin-3-ols. Synthesis and absolute configuration. Arkivoc. 10:107-117. doi: 10.3998/ark.5550190.0012.a09", "Grogan GJ, Holland HL (2000) The biocatalytic reactions of Beauveria spp. J Mol Catal B Enzym 9:1\u201332.", "Gross C, Felsheim R, Wackett LP (2008) Genes and enzymes of azetidine-2-carboxylate metabolism detoxification and assimilation of an antibiotic. J Bacteriol. 190(14):4859-4864. doi: 10.1128/JB.02022-07", "Guetzoyan L, Yu X-M, Ramiandrasoa F, Pethe S, Rogier C, Pradines B, Cresteil T, Perr\u00e9e-Fauvet M, Mahy J-P (2009) Antimalarial acridines: synthesis, in vitro activity against P. falciparum and interaction with hematin. Bioorg Med Chem 17:8032\u20138039.", "Hamilton P.B., Rosi D., Peruzzotti G.P., Nielson E.D. Microbiological metabolism of naphthyridines. Appl. Microbiol. 1969. V. 17. N 2. P.237-241.", "Hari G.S., Lee Y.R., Wang X., Lyoo W.S., Kim S.H. New synthetic routes to acronycine, noracronycine, and their analogues. Bull. Korean Chem. Soc. 2010. V. 31. N 8. P.2406-2409.", "Hassner A (2009) Adventures in stereochemistry and cycloadditions. Bull Israel Chem Soc. 24:20-25", "Hill JC, Johnson GT (1969) Microbial transformation of phenazines by Aspergillus sclerotiorum. Mycologia 61:452\u2013467.", "Hocart SJ, Liu H, Deng H, De D, Krogstad FM, Krogstad DJ (2011) 4-Aminoquinolines active against chloroquine-resistant Plasmodium falciparum: basis of antiparasite activity and quantitative structure-activity relationship analyses. Antimicrob. Agents Chemother. 55(5):2233-2244. doi: 10.1128/AAC.00675-10", "Hodgson DM, Fleming MJ, Xu Z, Lin C, Stanway SJ (2006) 3-Hydroxypyrrolidines from epoxysulfonamides and dimethylsulfoxonium methylide. Chem Commun. 30:3226\u20133228. doi: 10.1039/B606583J", "H\u00fcttel W, Hoffmeister D (2010) Fungal biotransformations in pharmaceutical sciences. The Mycota. 10(3):293-317. doi: 10.1007/978-3-642-11458-8_14", "H\u00fcttel W, Hoffmeister D (2010) Fungal biotransformations in pharmaceutical sciences. In: Hofrichter M (ed), The Mycota, Vol. 10, Industrial Applications, Springer, Berlin, pp 293\u2013317.", "Inoue K, Habe H, Yamane H, Nojiri H (2006) Characterization of novel carbazole catabolism genes from Gram-positive carbazole degrader Nocardioides aromaticivorans IC177. Appl Environ Microbiol 72:3321\u20133329", "Johansen SS, Licht D, Arvin E, Mosbaek H, Hansen AB (1997) Metabolic pathways of quinoline, indole and their methylated analogs by Desulfobacterium indolicum (DSM 3383). Appl Microbiol Biotechnol 47:292\u2013300.", "Johnson RA, Herr ME, Murray HC, Chidester CG, Han F (1992) Selective Oxygenation of Adamantanes and Other Substrates by Beauveria sulfurescens. J Org Chem. 57(26): 7209-7212. doi: 10.1021/jo00052a039", "Johnson RA, Herr ME, Murray HC, Fonken GS (1968a) The microbiological oxygenation of azacycloalkanes. Structural determinations leading to transannular reactions. J Org Chem. 33(8):3187-3195. doi: 10.1021/jo01272a035", "Johnson RA, Herr ME, Murray HC, Reineke LM, Fonken, GS (1968b) The microbiological oxygenation of some azabicycloalkanes. J Org Chem. 33(8):3195-3201. doi: 10.1021/jo01272a036", "Johnson RA, Murray HC, Reineke LM, Fonken GS (1969) Stereochemistry of microbiological hydroxylation. II. Oxygenation of 1-benzoylalkylpiperidines. J Org Chem. 34(8):2279-2284. doi: 10.1021/jo01260a009", "Jones M, Mercer AE, Stocks PA, La Pens\u00e9e LJ, Cosstick R, Park BK, Kennedy ME, Piantanida I, Ward SA, Davies J, Bray PG, Rawe SL, Baird J, Charidza T, Janneh O, O'Neill PM (2009) Antitumour and antimalarial activity of artemisinin-acridine hybrids. Bioorg Med Chem Lett 19:2033\u20132037", "Jones RN, Erwin ME, et al. In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry. Diagn. Microbiol. Infect. Dis. 1998. 32: 55-64.", "Jung C.M., Heinze T.M., Strakosha R., Elkins C.A., Sutherland J.B. Acetylation of fluoroquinolone antimicrobial agents by an Escherichia coli strain isolated from a municipal wastewater treatment plant. J. Appl. Microbiol. 2009. V. 106. P.564-571.", "Kaiser J-P, Feng Y, Bollag J-M (1996) Microbial metabolism of pyridine, quinoline, acridine, and their derivatives under aerobic and anaerobic conditions. Microbiol Rev 60:483\u2013498", "Kalkanidis M, Klonis N, Tilley L, Deady LW (2002) Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin. Biochem

Describes examples of the application of microbial technologies for obtaining of derivatives from a series of nitrogen heterocycles (saturated nitrogen heterocycles, azaarenes and quinolones). It is proposed alternative ways for synthesizing substances that are difficult to obtain by the methods of organic chemistry. Microbial technologies of synthesis of organic compounds may find out a practical application in the production of various drugs.